Medical Journals

Type Ii Nkt Cell-mediated Anergy Induction in Type I Nkt Cells Prevents Inflammatory Liver Disease.

Authors:
  • Halder Ramesh C
  • Aguilera Carlos
  • Maricic Igor
  • Kumar Vipin

From: Laboratory of Autoimmunity, Torrey Pines Institute for Molecular Studies, San Diego, California 92121, USA.

The Journal of clinical investigation

  • Publish Date: Aug 2007
  • ISSN: 0021-9738
  • Volume: 117
  • Issue: 8
  • Pages: 2302-12
  • Medium: Print
  • Language: English
  • Citation (JAMA): Halder Ramesh C, Aguilera Carlos, Maricic Igor, et al. Type Ii Nkt Cell-mediated Anergy Induction in Type I Nkt Cells Prevents Inflammatory Liver Disease.. J. Clin. Invest. Aug 2007;117:2302-12

Abstract

Because of the paucity of known self lipid-reactive ligands for NKT cells, interactions among distinct NKT cell subsets as well as immune consequences following recognition of self glycolipids have not previously been investigated. Here we examined cellular interactions and subsequent immune regulatory mechanism following recognition of sulfatide, a self-glycolipid ligand for a subset of CD1d-restricted type II NKT cells. Using glycolipid/CD1d tetramers and cytokine responses, we showed that activation of sulfatide-reactive type II NKT cells and plasmacytoid DCs caused IL-12- and MIP-2-dependent recruitment of type I, or invariant, NKT (iNKT) cells into mouse livers. These recruited iNKT cells were anergic and prevented concanavalin A-induced (ConA-induced) hepatitis by specifically blocking effector pathways, including the cytokine burst and neutrophil recruitment that follow ConA injection. Hepatic DCs from IL-12(+/+) mice, but not IL-12(-/-) mice, adoptively transferred anergy in recipients; thus, IL-12 secretion by DCs enables them to induce anergy in iNKT cells. Our data reveal what we believe to be a novel mechanism in which interactions among type II NKT cells and hepatic DCs result in regulation of iNKT cell activity that can be exploited for intervention in inflammatory diseases, including autoimmunity and asthma.

Mesh Headings (Keywords): Animals, Antigens, CD1, Asthma, Autoantigens, Autoimmunity, Chemokine CXCL2, Chemokines, Clonal Anergy, Dendritic Cells, Hepatitis, Interleukin-12, Killer Cells, Natural, Ligands, Liver, Mice, Mice, Knockout, Sulfoglycosphingolipids, T-Lymphocytes


Check for Full Text / PubMed Unique Identifier (PMID): 17641782


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.